Public COA audit

Tirzepatide · GLP TZ

Audited July 28, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
85%
Panels
3/7
Purity (printed)
99.617%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
GT30-032026-4
Identity method
HPLC with UV Detection Coupled with Mass Spectrometry
Sample date
2026-03-20
Issue date
2026-03-22

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    GLP TZ confirmed at 99.617%

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.617%

  • Heavy metals

    Not on this COA

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    Replicate 1: Pass, Replicate 2: Pass

  • Sterility

    Not on this COA

    Sterility testing where applicable.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    HPLC purity of 99.617% with supporting chromatogram showing clean single peak

  • Mass spec confirmation

    Mass spectrometry data shows expected molecular ion peaks [M+4H]4+ at 1204.10 and [M+3H]3+ at 1605.25, consistent with tirzepatide

  • Endotoxin testing performed

    Duplicate endotoxin threshold tests both passed

  • Lab verification unclear

    Freedom Diagnostics claims to be 'Proudly Owned and Operated in the USA' but independent verification of lab accreditation/credentials not readily available from document

  • Inconsistent compound naming

    Product listed as 'Tirzepatide 30mg' but identity shows 'GLP TZ' and 'GLP 1Z' - inconsistent nomenclature may indicate template reuse

  • Batch information present

    Lot number GT30-032026-4 and accession number 2603200152 provided

  • Dates within normal range

    Received 2026-03-20, reported 2026-03-22 - 2 day turnaround is reasonable

  • Limited testing scope

    No heavy metals, microbial, sterility, or residual solvent testing reported - common for research-grade but limits comprehensive safety assessment

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.